本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Guided Therapeutics, Inc.

0.1400
0.0000
成交量:- -
成交额:- -
市值:1,091.55万
市盈率:-0.49
高:0.1400
开:0.1400
低:0.1400
收:0.1400
数据加载中...
2025/05/16

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/31

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/12/21

重要事件披露

Form 8-K - Current report
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/27

重要事件披露

Form 8-K - Current report
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/20

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/16

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/09

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/23

SEC问询函

CORRESP [Cover] - Correspondence
2023/01/13

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/24

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals